24 of the most important questions about psychedelics, answered | Matthew Johnson: Full Interview
Quick Overview
Matthew Johnson, a professor of psychiatry and behavioral sciences at Johns Hopkins, explains that psychedelics like psilocybin and LSD are unique because many users report profound, life-altering benefits from just a single use, unlike other drug classes, and clarifies that the term 'psychedelic' means 'mind manifesting' and is preferable to 'hallucinogen' because it encompasses deeper subjective effects beyond just visual distortions.
Key Points: Psychedelics are the only drug class where countless people claim profound, beneficial effects impacting the entire course of their life after only one use, a claim Johnson does not hear from users of cannabis or other substances. The term 'psychedelic' was coined by Humphry Osmond, meaning 'mind manifesting,' which Johnson prefers over 'hallucinogen' because the primary effects are often deep internal insights rather than true hallucinations, as reality testing usually remains intact. Classic psychedelics (psilocybin, LSD, DMT, mescaline) primarily work by activating the serotonin 2A receptor, which acts as the first domino, leading to downstream effects involving the glutamate system and massive increases in communication across normally compartmentalized brain areas. The greatest risks associated with classic psychedelics are destabilizing individuals with active psychosis like schizophrenia or bipolar disorder, and the potential for anxiety/fear during a 'challenging experience' (bad trip). In harm rankings based on objective data, psilocybin mushrooms and LSD consistently rank at the lowest end for harm to self and harm to society compared to other major psychoactive compounds like tobacco and alcohol. The first wave of research in the 1950s, led by groups like Abram Hoffer and Humphry Osmond in Saskatchewan, developed 'psychedelic therapy,' moving beyond merely mimicking psychosis to fostering meaningful, clear, and insightful experiences. MDMA differs pharmacologically from classic psychedelics by causing the serotonin-releasing neuron (the 'pitcher') to throw out a massive increase in serotonin, rather than mimicking serotonin at the receptor site (the 'catcher's mitt').